Home > > > Bioresorbable Vascular Scaffold Market Set to Grow at 7.8% CAGR Through 2031

Bioresorbable Vascular Scaffold Market Set to Grow at 7.8% CAGR Through 2031

Author : kaustubh Ravan | Published On : 28 Apr 2026

The global bioresorbable vascular scaffold market was valued at USD 161.5 million in 2022 and is projected to surpass USD 316.7 million by 2031, expanding at a CAGR of 7.8% from 2023 to 2031. Market growth is driven by increasing prevalence of cardiovascular diseases and rising demand for advanced, minimally invasive treatment options. Bioresorbable scaffolds, which naturally dissolve in the body over time, are gaining popularity due to their ability to reduce long-term complications associated with permanent stents. Ongoing technological advancements and growing healthcare investments are further supporting market expansion.

Dive Deeper into Data: Get Your In-Depth Sample Now! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=32003

The global bioresorbable vascular scaffold market is expected to witness significant growth in the next few years due to rise in prevalence of cardiovascular diseases and rise in demand for minimally invasive procedures. Moreover, rise in healthcare expenditure along with increase in awareness about the advantages of BVS over traditional metallic stents is contributing to the global bioresorbable vascular scaffold market expansion.

Key manufacturers in the market are investing in research & development activities to develop innovative products and expand their product portfolio. The market is highly competitive, with players focusing on strategic partnerships and collaborations to expand market presence. However, high cost of BVS and lack of reimbursement policies in some regions are projected to hamper market statistics in the near future.

Key Findings of the Market Report

  • Polymer-based BVS (primarily PLLA) account for the majority of the market (62%–76%), while Magnesium-based versions are gaining traction for complex lesions.
  • Coronary Artery Disease (CAD) is the primary application, accounting for 67.3% of the market share in 2026.
  • Hospitals remain the leading end-user (66.3% – 74.2% share), though Ambulatory Surgical Centers (ASCs) are the fastest-growing channel due to the rise in outpatient PCI procedures.
  • Thinner strut technology is a major trend, with 54% of new devices shifting toward designs that reduce inflammation and improve vessel healing.

Global Market: Growth Drivers

  • "Leave Nothing Behind" Clinical Philosophy: Increasing preference for temporary implants that restore vascular function without permanent metallic footprints.
  • Rising Prevalence of CVD: An aging global population and rising rates of diabetes are driving higher volumes of percutaneous coronary interventions (PCI).
  • Technological Advances in Materials: The development of second-generation scaffolds with thinner struts and controlled degradation has significantly improved safety profiles.
  • Expanding Indications in Younger Patients: Younger populations are increasingly receiving BVS to preserve future treatment options like bypass grafting.

Global Market: Key Players

The competitive landscape is moderately concentrated, with established med-tech giants leading through extensive clinical trial participation and strategic R&D in biomaterials.

  • Abbott Laboratories (21% market share)
  • Medtronic PLC (18% market share)
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Terumo Corporation
  • Elixir Medical Corporation
  • REVA Medical, LLC
  • MicroPort Scientific Corporation
  • Meril Life Sciences Pvt. Ltd.
  • Arterial Remodeling Technologies S.A.

Global Market: Segmentation

By Material

  • Polymer-based (PLLA, PLGA) - Volume Leader
  • Metal-based (Magnesium, Zinc) - High Growth
  • Hybrid Scaffolds

By Application

  • Coronary Artery Disease (CAD)
  • Peripheral Artery Disease (PAD)

By End-User

  • Hospitals & Cardiac Centers
  • Ambulatory Surgical Centers (ASCs)
  • Research & Academic Institutes

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=32003&ltype=S

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com 
Sales Inquiries: sales@transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com